A Case of Voltage-Gated Potassium Channel Antibody-Related Limbic Encephalitis
Nat Clin Pract Neurol 2:339-343, Harrower,T., et al, 2006
Psychiatric Presentation of Voltage-Gated Potassium Channel Antibody-Associated Encephalopathy
Br J Psychiatry 189:182-183, Parathasarathi,U.D., et al, 2006
ANCA-Associated Vasculitis (AAV) causing Bilateral Cerebral Infarction and Subsequent Intracerebral Hemorrhage without Renal and Respiratory Dysfunction
J Neurol Sci 240:99-101, Ito, Y.,et al, 2006
Isolated Abducens Nerve Palsy as a Regional Variant of Guillain-Barre Syndrome
JNS 243:35-38, Tatsumoto, M.,et al, 2006
A New Cause of Limbic Encephalopathy
Brain 128:1745-1746, Darnell,R.B., et al, 2005
Treatment-Responsive Limbic Encephalitis Identified by Neuropil Antibodies: MRI and PET Correlates
Brain 128:1764-1777, Ances,B.M., et al, 2005
Paraneoplastic Limbic Encephalitis
Eur Neurol 53:106-108, Pearce, J.M.S., 2005
Immune-mediated rippling muscle disease
Neurol 64:364 367, Schulte-Mattler, W.J., et al, 2005
Spinal Cord Transient Ischemic Attacks: A Possible Role for Abciximab
Neurol 64: 761-762, Hussain, M.S., et al, 2005
Clinicopath Conf, Human Granulocytic Ehrlichiosis
NEJM 352:1358-1364, Case 10-2005, 2005
Anti-a4 Integrin Therapy for Multiple Sclerosis
Neurol 64:1336-1342, Rice,G.P.A.,et al, 2005
Does This Patient Have Myasthenia Gravis?
JAMA 293:1906-1914, Scherer,K.,et al, 2005
Anti-Sulfatide Antibodies in HIV-Infected Individuals with Sensory Neuropathy
Neurol 64:1632-1634, Lopate,G.,et al, 2005
Autoantibodies to Folate Receptors in the Cerebral Folate Deficiency Syndrome
NEJM 352:1985-1991, Ramaekers,V.T.,et al, 2005
FDA Public Health advisory-Suspended Marketing of Tysabri (natalizumab)
www.fda.gov/cder/drug/advisory/natalizumab.htm.,(Feb 28), US Food and Drug Admin., 2005
The "Pulvinar Sign" in a Case of Paraneoplastic Limbic Encephalitis Associated with Non-Hodgkins Lymphoma
JNNP 76:882-884, Mihara,M.,et al, 2005
Temporal Relationship Between Elevation of Epstein-Barr Virus Antibody Titers and Initial Onset of Neurological Symptoms in Multiple Sclerosis
JAMA 293:2496-2500, Levin,L.I.,et al, 2005
Rabies Encephalomyelitis
Arch Neurol 62:873-882,855, Burton,E.C.,et al, 2005
Survival after Treatment of Rabies with Induction of Coma
NEJM 352:2508-2514,2549, Willoughby,Jr.,R.E.,et al, 2005
Neutralizing Anti-IFN-B Antibodies
Neurol 65:6-8, Giovannoni,G.&Goodman,A., 2005
Clinicopath Conf,Encephalomyelitis Due to West Nile Virus and CLL, Case 22-2005
NEJM 353:287-295, Hollande,H.,et al, 2005
Progressive Multifocal Leukoencephalopathy Complicating Treatment with Natalizumab and Interferon Beta-1a for Multiple Sclerosis
NEJM 353:369-374,414,432, Kleinschemidt-DeMasters,B.K. &Tyler,K.L., 2005
Progressive Multifocal Leukoencephalopathy After Natalizumab Therapy for Crohns Disease
NEJM 353:362-368, Van Assche,G.,et al, 2005
Progressive Multifocal Leukoencephalopathy in a Patient Treated with Natalizumab
NEJM 353:375-381, Langer-Gould,A.,et al, 2005
Dysphagia as the Sole Manisfestation of Myasthenia Gravis
JNNP 76:1297-1300, Llabrs,M.,et al, 2005
Fatal Brain Necrosis in Primary HIV Infection
Lancet 366:866, Meersseman,W.,et al, 2005
Agressive Therapy With Intravenous Abciximab and Intra-Arterial rtPA and Additional PTA/Stenting Improves Clinical Outcome in Acute Vertebrobasilar Occlusion
Stroke 36:1160-1165, Eckert,B.,et al, 2005
Reversal of Dense Signs Predicts Recovery in Acute Ischemic Stroke
Stroke 36:e2490-e2492, Mandava,P. &Kent,T.A., 2005
Autoantibodies in Postinfectious Acute Cerebellar Ataxia
Neurol 65:1114-1116, Uchibori,A.,et al, 2005
Infliximab and Reactivation of Cerebral Toxoplasmosis
NEJM 353:1530-1531, Callegari,P.E., 2005
Guillain-Barre Syndrome
Lancet 366:1653-1666, Hughes,R.C. &Comblath,D.R., 2005
Efficacy of TNF a Blockade in Cyclophosphamide Resistant Neuro-Behet Disease
JNNP 76:1733-1735, Ribi,C.,et al, 2005
Recurrent Transverse Myelitis Associates with Anti-Ro (SSA) Autoantibodies
Neurol 62:147-149, Hummers,L.K.,et al, 2004
Fatal Myositis Due to the Microsporidian Brachiola algerae, a Mosquito Pathogen
NEJM 351:42-47, Coyle,C.M.,et al, 2004
Anti-GQ1b Ganglioside Antibody in Peripheral Nervous System Disorders
Arch Neurol 61:1013-1016, Paparounas,K., 2004
Antiphospholipid Antibodies and Subsequent Thrombo-occlusive Events in Patients with Ischemic Stroke
JAMA 291:576-584, The APASS Investigators, 2004
Memantine Treatment in Patients with Moderate to Severe Alzheimer Disease Already Receiving Donepezil, A Randomized Controlled Trial
JAMA 291:317-324, Tariot,P.N.,et al, 2004
Anticardiolipin Antibodies and Risk of Ischemic Stroke and Transient Ischemic Attack
Stroke 35:736-741, Janardhan,V.,et al, 2004
Acute Facial Diplegia and Hyperreflexia
Neurol 62:825-827, Susuki,K.,et al, 2004
Variants and Mimics of Guillain Barre Syndrome
The Neurologist 10:61-74, Levin,K.H., 2004
An Unusual Cause of Psychosis
Lancet 363:1522, Singh,S.,et al, 2004
Paraneoplastic "Stiff Person Syndrome" with Metastatic Adenocarcinoma and anti-Ri Antibodies
Neurol 62:1402-1404, McCabe,D.J.H.,et al, 2004
Epstein-Barr Virus in Pediatric Multiple Sclerosis
JAMA 291:1875-1879, Alotaibi,S.,et al, 2004
Progressive Binasal Hemianopia
Lancet 363:1606, Pringle,E.,et al, 2004
Stiff-Person Syndrome
The Neurologist 10:131-137, Murinson,B.B., 2004
MR Findings in Hashimoto Encephalopathy
AJNR 25:807-808, Song,Y.M.,et al, 2004
Are MuSK Antibodies the Primary Cause of Myasthenic Symptoms?
Neurol 62:1945-1950,1920, Selcen,D.,et al, 2004
Management of Myasthenia Gravis
Semin Neurol 24:41-48, Saperstein,D.S. &Barohn,R.J., 2004
Recommended Diagnostic Criteria for Paraneoplastic Neurological Syndromes
JNNP 75:1135-1140,1090, Graus,F.,et al, 2004
West Nile Virus Infection in the United States
Arch Neurol 61:1190-1195, Tyler,K.L., 2004